MeiraGTx Holdings (MGTX) Other Working Capital Changes (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Other Working Capital Changes came in at $65000.0 in Q3 2025, up 212.07% YoY from $20828.7 in Q3 2024, and up 131.1% on a QoQ basis from -$209000.0 in Q2 2025.
MeiraGTx Holdings (MGTX) Other Working Capital Changes (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 4 years of Other Working Capital Changes data on file, last reported at $65000.0 in Q3 2025.
- Quarterly Other Working Capital Changes rose 212.07% year-over-year to $65000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $101000.0 (up 144.49% YoY) and the FY2024 annual result came in at $16000.0, up 107.21% from the prior year.
- Other Working Capital Changes grew to $65000.0 in Q3 2025, from -$209000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $24.8 million in Q3 2024 to a low of -$10.8 million in Q2 2022.
- A 5-year average of $940050.0 and a median of -$304000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 352.17% — and 2025, when it sank 226.56%.
- Tracing MGTX's Other Working Capital Changes over 4 years: stood at -$68000.0 in 2022, then retreated by 1.47% to -$69000.0 in 2023, then soared by 352.17% to $174000.0 in 2024, then tumbled by 62.64% to $65000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $65000.0 (Q3 2025), -$209000.0 (Q2 2025), and $71000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 699,000.00 |
| Sep 30, 2025 | 699,000.00 |
| Sep 30, 2025 | 699,000.00 |
| Jun 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Mar 31, 2025 | -329,000.00 |
| Mar 31, 2025 | -329,000.00 |
| Mar 31, 2025 | -329,000.00 |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 24.77 Mn |
| Sep 30, 2024 | 24.77 Mn |
| Sep 30, 2024 | 24.77 Mn |
| Jun 30, 2024 | -279,000.00 |
| Jun 30, 2024 | -279,000.00 |